The WACC of Supernus Pharmaceuticals Inc (SUPN) is 5.8%.
Range | Selected | |
Cost of equity | 7.20% - 9.50% | 8.35% |
Tax rate | 24.20% - 25.70% | 24.95% |
Cost of debt | 4.00% - 4.50% | 4.25% |
WACC | 5.1% - 6.4% | 5.8% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.72 | 0.83 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 7.20% | 9.50% |
Tax rate | 24.20% | 25.70% |
Debt/Equity ratio | 1 | 1 |
Cost of debt | 4.00% | 4.50% |
After-tax WACC | 5.1% | 6.4% |
Selected WACC | 5.8% | |